These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 12913228)
1. Investigation and physicochemical characterization of vinpocetine-sulfobutyl ether beta-cyclodextrin binary and ternary complexes. Ribeiro L; Loftsson T; Ferreira D; Veiga F Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):914-22. PubMed ID: 12913228 [TBL] [Abstract][Full Text] [Related]
2. Physicochemical investigation of the effects of water-soluble polymers on vinpocetine complexation with beta-cyclodextrin and its sulfobutyl ether derivative in solution and solid state. Ribeiro LS; Ferreira DC; Veiga FJ Eur J Pharm Sci; 2003 Nov; 20(3):253-66. PubMed ID: 14592691 [TBL] [Abstract][Full Text] [Related]
3. Multicomponent complex formation between vinpocetine, cyclodextrins, tartaric acid and water-soluble polymers monitored by NMR and solubility studies. Ribeiro L; Carvalho RA; Ferreira DC; Veiga FJ Eur J Pharm Sci; 2005 Jan; 24(1):1-13. PubMed ID: 15626573 [TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of binary and ternary cyclodextrin complexes with econazole nitrate in solution and in solid state. Jug M; Mennini N; Kövér KE; Mura P J Pharm Biomed Anal; 2014 Mar; 91():81-91. PubMed ID: 24444785 [TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of zaleplon complexation with cyclodextrins and hydrophilic polymers in solution and in solid state. Jablan J; Szalontai G; Jug M J Pharm Biomed Anal; 2012 Dec; 71():35-44. PubMed ID: 22898722 [TBL] [Abstract][Full Text] [Related]
6. In vitro controlled release of vinpocetine-cyclodextrin-tartaric acid multicomponent complexes from HPMC swellable tablets. Ribeiro L; Ferreira DC; Veiga FJ J Control Release; 2005 Mar; 103(2):325-39. PubMed ID: 15763617 [TBL] [Abstract][Full Text] [Related]
7. The influence of polyvinylpyrrolidone on naproxen complexation with hydroxypropyl-beta-cyclodextrin. Mura P; Faucci MT; Bettinetti GP Eur J Pharm Sci; 2001 May; 13(2):187-94. PubMed ID: 11297903 [TBL] [Abstract][Full Text] [Related]
8. The investigation of binary and ternary sulfobutylether-β-cyclodextrin inclusion complexes with asiaticoside in solution and in solid state. Soe HMH; Chamni S; Mahalapbutr P; Kongtaworn N; Rungrotmongkol T; Jansook P Carbohydr Res; 2020 Dec; 498():108190. PubMed ID: 33160203 [TBL] [Abstract][Full Text] [Related]
9. Effect of auxiliary substances on complexation efficiency and intrinsic dissolution rate of gemfibrozil-beta-CD complexes. Sami F; Philip B; Pathak K AAPS PharmSciTech; 2010 Mar; 11(1):27-35. PubMed ID: 20013079 [TBL] [Abstract][Full Text] [Related]
10. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine. Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388 [TBL] [Abstract][Full Text] [Related]
11. Voriconazole Eye Drops: Enhanced Solubility and Stability through Ternary Voriconazole/Sulfobutyl Ether β-Cyclodextrin/Polyvinyl Alcohol Complexes. Soe HMSH; Kerdpol K; Rungrotmongkol T; Pruksakorn P; Autthateinchai R; Wet-Osot S; Loftsson T; Jansook P Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768671 [TBL] [Abstract][Full Text] [Related]
12. Multicomponent complexes of piroxicam with cyclodextrins and hydroxypropyl methylcellulose. Jug M; Bećirević-Laćan M Drug Dev Ind Pharm; 2004; 30(10):1051-60. PubMed ID: 15595571 [TBL] [Abstract][Full Text] [Related]
13. Investigation and physicochemical characterization of clarithromycin-citric acid-cyclodextrins ternary complexes. Zhang X; Zhang Y; Zhong D; Chen Y; Li S Drug Dev Ind Pharm; 2007 Feb; 33(2):163-71. PubMed ID: 17454048 [TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization and in vitro dissolution study of Nitrazepam: Cyclodextrin inclusion complex. Patel JS; Patel RP J Pharm Bioallied Sci; 2012 Mar; 4(Suppl 1):S106-7. PubMed ID: 23066180 [TBL] [Abstract][Full Text] [Related]
15. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances. Srivalli KM; Mishra B AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622 [TBL] [Abstract][Full Text] [Related]
16. Nimesulide and beta-cyclodextrin inclusion complexes: physicochemical characterization and dissolution rate studies. Chowdary KP; Nalluri BN Drug Dev Ind Pharm; 2000 Nov; 26(11):1217-20. PubMed ID: 11068697 [TBL] [Abstract][Full Text] [Related]
17. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies. Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111 [TBL] [Abstract][Full Text] [Related]
19. Interactions of griseofulvin with cyclodextrins in solid binary systems. Veiga MD; Díaz PJ; Ahsan F J Pharm Sci; 1998 Jul; 87(7):891-900. PubMed ID: 9649360 [TBL] [Abstract][Full Text] [Related]
20. Analysis of physicochemical properties of ternary systems of oxaprozin with randomly methylated-ß-cyclodextrin and l-arginine aimed to improve the drug solubility. Mennini N; Maestrelli F; Cirri M; Mura P J Pharm Biomed Anal; 2016 Sep; 129():350-358. PubMed ID: 27454086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]